Inventory Turnover: A ratio showing how many times a company's inventory is sold and replaced over a period. Calculated as: Cost of Goods Sold / Total Inventory
Revance Therapeutics, Inc. (RVNC) had Inventory Turnover of 1.63 for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$234.04M |
|
$-323.99M |
|
$74.36M |
|
$159.68M |
|
$550.82M |
|
$-316.78M |
|
$-6.91M |
|
$-323.69M |
|
$-323.69M |
|
$-323.99M |
|
$-323.99M |
|
$-323.99M |
|
$-323.99M |
|
$-316.78M |
|
$-213.94M |
|
84.60M |
|
84.60M |
|
$-3.83 |
|
$-3.83 |
|
| Balance Sheet Financials | |
$338.87M |
|
$17.23M |
|
$139.59M |
|
$478.45M |
|
$89.22M |
|
$426.60M |
|
$540.83M |
|
$630.06M |
|
$-151.60M |
|
$-161.41M |
|
$-151.60M |
|
87.96M |
|
| Cash Flow Statement Financials | |
$-216.57M |
|
$109.74M |
|
$136.57M |
|
$115.02M |
|
$144.75M |
|
$29.73M |
|
$47.81M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.80 |
|
-- |
|
-- |
|
1.55 |
|
-2.85 |
|
68.23% |
|
-135.35% |
|
-135.35% |
|
-91.41% |
|
-138.30% |
|
-138.43% |
|
$-223.46M |
|
-- |
|
-- |
|
-- |
|
0.49 |
|
|
Inventory Turnover |
1.63 |
8.46 |
|
43.16 |
|
213.71% |
|
200.72% |
|
-67.72% |
|
-117.82% |
|
$-1.72 |
|
$-2.64 |
|
$-2.56 |
|